Does SEMAGLUTIDE Cause Stent placement? 27 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Stent placement have been filed in association with SEMAGLUTIDE (WEGOVY). This represents 0.1% of all adverse event reports for SEMAGLUTIDE.
27
Reports of Stent placement with SEMAGLUTIDE
0.1%
of all SEMAGLUTIDE reports
0
Deaths
10
Hospitalizations
How Dangerous Is Stent placement From SEMAGLUTIDE?
Of the 27 reports, 10 (37.0%) required hospitalization.
Is Stent placement Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SEMAGLUTIDE. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does SEMAGLUTIDE Cause?
Nausea (10,036)
Vomiting (6,518)
Off label use (5,425)
Diarrhoea (5,331)
Decreased appetite (4,317)
Constipation (4,036)
Weight decreased (3,518)
Impaired gastric emptying (2,622)
Product use in unapproved indication (2,613)
Wrong technique in product usage process (2,538)
What Other Drugs Cause Stent placement?
RANOLAZINE (593)
EVOLOCUMAB (244)
ADALIMUMAB (227)
ROSIGLITAZONE (196)
ETANERCEPT (174)
CLOPIDOGREL BISULFATE (167)
RIVAROXABAN (122)
ASPIRIN (118)
APIXABAN (116)
MACITENTAN (108)
Which SEMAGLUTIDE Alternatives Have Lower Stent placement Risk?
SEMAGLUTIDE vs SEMUSTINE
SEMAGLUTIDE vs SENNA LEAF
SEMAGLUTIDE vs SENNA LEAF\SENNOSIDES\SENNOSIDES A AND B
SEMAGLUTIDE vs SENNOSIDES
SEMAGLUTIDE vs SENNOSIDES A AND B